|
WO1994015909A1
(en)
|
1993-01-14 |
1994-07-21 |
Magainin Pharmaceuticals, Inc. |
Amino acids and peptides having modified terminals
|
|
US5654451B1
(en)
|
1993-01-14 |
2000-02-22 |
Magainin Pharma |
Amino acids and peptides having modified c-terminals and modified n-terminals
|
|
EP1532118A2
(en)
|
2002-07-05 |
2005-05-25 |
Axxima Pharmaceuticals Aktiengesellschaft |
Imidazole compounds for the treatment of hepatitis c virus infections
|
|
AU2003261434A1
(en)
|
2002-08-12 |
2004-02-25 |
Bristol-Myers Squibb Company |
Iminothiazolidinones as inhibitors of hcv replication
|
|
DE102004036971B4
(de)
|
2004-07-30 |
2009-07-30 |
Advanced Micro Devices, Inc., Sunnyvale |
Technik zur Bewertung lokaler elektrischer Eigenschaften in Halbleiterbauelementen
|
|
WO2006022442A1
(ja)
|
2004-08-24 |
2006-03-02 |
Santen Pharmaceutical Co., Ltd. |
ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
|
|
US7894996B2
(en)
|
2005-02-28 |
2011-02-22 |
The Rockefeller University |
Structure of the hepatitis C NS5A protein
|
|
US8143288B2
(en)
|
2005-06-06 |
2012-03-27 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
|
PT1940786E
(pt)
|
2005-09-16 |
2010-10-04 |
Arrow Therapeutics Ltd |
Derivados de bifenilo e sua utilização no tratamento de hepatite c
|
|
WO2007058384A1
(en)
|
2005-11-17 |
2007-05-24 |
Osaka University |
Method of suppressing replication of hepatitis c virus, inhibitor of replication of the virus and method of screening for the same
|
|
US7915411B2
(en)
|
2005-12-21 |
2011-03-29 |
Abbott Laboratories |
Anti-viral compounds
|
|
KR20080080395A
(ko)
|
2005-12-21 |
2008-09-03 |
아보트 러보러터리즈 |
항바이러스 화합물
|
|
SG133452A1
(en)
|
2005-12-30 |
2007-07-30 |
Novartis Ag |
Peptide deformylase inhibitors for treatment of mycobacterial and other parasitic diseases
|
|
WO2007138242A1
(en)
|
2006-05-30 |
2007-12-06 |
Arrow Therapeutics Limited |
Biphenyl derivatives and their use in treating hepatitis c
|
|
US8329159B2
(en)
|
2006-08-11 |
2012-12-11 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US20100158862A1
(en)
|
2006-08-11 |
2010-06-24 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US7745636B2
(en)
|
2006-08-11 |
2010-06-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8303944B2
(en)
|
2006-08-11 |
2012-11-06 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US7759495B2
(en)
|
2006-08-11 |
2010-07-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
CN101558059B
(zh)
*
|
2006-08-11 |
2014-12-03 |
百时美施贵宝公司 |
丙型肝炎病毒抑制剂
|
|
US7659270B2
(en)
|
2006-08-11 |
2010-02-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US20100055071A1
(en)
|
2006-11-21 |
2010-03-04 |
Martin Robert Leivers |
Anti-Viral Compounds
|
|
TWI399380B
(zh)
|
2006-12-20 |
2013-06-21 |
Abbott Lab |
抗病毒化合物
|
|
US7741347B2
(en)
|
2007-05-17 |
2010-06-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US7728027B2
(en)
|
2007-08-08 |
2010-06-01 |
Bristol-Myers Squibb Company |
Process for synthesizing compounds useful for treating hepatitis C
|
|
US8629171B2
(en)
|
2007-08-08 |
2014-01-14 |
Bristol-Myers Squibb Company |
Crystalline form of methyl ((1S)-1-((25)-2-(5-(4'-(2-((25)-1((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt
|
|
CN102015692A
(zh)
|
2008-02-12 |
2011-04-13 |
百时美施贵宝公司 |
丙型肝炎病毒抑制剂
|
|
US7704992B2
(en)
|
2008-02-13 |
2010-04-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8147818B2
(en)
|
2008-02-13 |
2012-04-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US7906655B2
(en)
|
2008-08-07 |
2011-03-15 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8383094B2
(en)
|
2008-10-01 |
2013-02-26 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8729077B2
(en)
|
2008-11-28 |
2014-05-20 |
Glaxosmithkline Llc |
Anti-viral compounds, compositions, and methods of use
|
|
JP2012510525A
(ja)
|
2008-12-03 |
2012-05-10 |
プレシディオ ファーマシューティカルズ インコーポレイテッド |
Hcvns5aの阻害剤
|
|
KR101784830B1
(ko)
|
2008-12-03 |
2017-10-16 |
프레시디오 파마슈티칼스, 인코포레이티드 |
Hcv ns5a의 억제제
|
|
CA2740193A1
(en)
|
2008-12-23 |
2010-07-01 |
Abbott Laboratories |
Anti-viral compounds
|
|
EP2393359A4
(en)
|
2009-02-09 |
2012-10-03 |
Enanta Pharm Inc |
COMPOUND DIBENZIMIDAZOLE DERIVATIVES
|
|
TWI438200B
(zh)
|
2009-02-17 |
2014-05-21 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
|
WO2010096462A1
(en)
|
2009-02-17 |
2010-08-26 |
Enanta Pharmaceuticals, Inc |
Linked diimidazole derivatives
|
|
WO2010094977A1
(en)
|
2009-02-23 |
2010-08-26 |
Arrow Therapeutics Limited |
Novel biphenyl compounds useful for the treatment of hepatitis c
|
|
EP2398474A4
(en)
|
2009-02-23 |
2012-12-05 |
Presidio Pharmaceuticals Inc |
HCV NS5A SHEMMER
|
|
WO2010099527A1
(en)
|
2009-02-27 |
2010-09-02 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
EA020898B1
(ru)
|
2009-03-27 |
2015-02-27 |
Мерк Шарп Энд Домэ Корп. |
Ингибиторы репликации вируса гепатита c
|
|
US8709999B2
(en)
|
2009-03-27 |
2014-04-29 |
Presidio Pharmaceuticals, Inc. |
Substituted bicyclic HCV inhibitors
|
|
SG174883A1
(en)
|
2009-03-27 |
2011-11-28 |
Presidio Pharmaceuticals Inc |
Fused ring inhibitors of hepatitis c
|
|
US8796466B2
(en)
|
2009-03-30 |
2014-08-05 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US20110237636A1
(en)
|
2009-03-30 |
2011-09-29 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
TWI476190B
(zh)
|
2009-03-30 |
2015-03-11 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
|
TW201038559A
(en)
|
2009-04-09 |
2010-11-01 |
Bristol Myers Squibb Co |
Hepatitis C virus inhibitors
|
|
US8143414B2
(en)
|
2009-04-13 |
2012-03-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
MX2011010905A
(es)
|
2009-04-15 |
2011-11-01 |
Abbott Lab |
Compuestos antivirales.
|
|
JP2012524761A
(ja)
|
2009-04-24 |
2012-10-18 |
テイボテク・フアーマシユーチカルズ |
ジアリールエーテル類
|
|
US9139569B2
(en)
|
2009-05-12 |
2015-09-22 |
Merck Sharp & Dohme Corp. |
Fused tricyclic aryl compounds useful for the treatment of viral diseases
|
|
LT2873665T
(lt)
|
2009-05-13 |
2016-10-25 |
Gilead Pharmasset Llc |
Antivirusiniai junginiai
|
|
US8138215B2
(en)
|
2009-05-29 |
2012-03-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8211928B2
(en)
|
2009-05-29 |
2012-07-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
CA2762885A1
(en)
|
2009-05-29 |
2010-12-02 |
Schering Corporation |
Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c
|
|
US8980920B2
(en)
|
2009-05-29 |
2015-03-17 |
Merck Sharp & Dohme Corp. |
Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis C
|
|
RS52854B
(sr)
|
2009-06-11 |
2013-12-31 |
Abbvie Bahamas Limited |
Inhibitori hepatitis c virusa
|
|
US9394279B2
(en)
|
2009-06-11 |
2016-07-19 |
Abbvie Inc. |
Anti-viral compounds
|
|
US8937150B2
(en)
|
2009-06-11 |
2015-01-20 |
Abbvie Inc. |
Anti-viral compounds
|
|
WO2010148006A1
(en)
|
2009-06-16 |
2010-12-23 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
WO2011004276A1
(en)
|
2009-07-06 |
2011-01-13 |
Pfizer Limited |
Hepatitis c virus inhibitors
|
|
CN102656160A
(zh)
|
2009-07-16 |
2012-09-05 |
顶点制药公司 |
用于治疗或预防黄病毒感染的苯并咪唑类似物
|
|
CA2768638A1
(en)
|
2009-08-07 |
2011-02-10 |
Tibotec Pharmaceuticals |
Bis-benzimidazole derivatives as hepatitis c virus inhibitors
|
|
CA2768637A1
(en)
|
2009-08-07 |
2011-02-10 |
Tibotec Pharmaceuticals |
Phenyl ethynyl derivatives as hepatitis c virus inhibitors
|
|
US20120172368A1
(en)
|
2009-09-03 |
2012-07-05 |
Koen Vandyck |
Bis-Benzimidazole Derivatives
|
|
CA2771327A1
(en)
|
2009-09-04 |
2011-03-10 |
Glaxosmithkline Llc |
Chemical compounds
|
|
EP2475256A4
(en)
|
2009-09-11 |
2013-06-05 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
|
WO2011031934A1
(en)
|
2009-09-11 |
2011-03-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
US8415374B2
(en)
|
2009-10-12 |
2013-04-09 |
Bristol-Myers Squibb Company |
Combinations of hepatitis C virus inhibitors
|
|
WO2011050146A1
(en)
|
2009-10-23 |
2011-04-28 |
Glaxosmithkline Llc |
Chemical compounds
|
|
UA108211C2
(uk)
|
2009-11-04 |
2015-04-10 |
Янссен Рід Айрленд |
Бензімідазолімідазольні похідні
|
|
US20110269956A1
(en)
|
2009-11-11 |
2011-11-03 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US20110274648A1
(en)
*
|
2009-11-11 |
2011-11-10 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US20110281910A1
(en)
|
2009-11-12 |
2011-11-17 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US20120276047A1
(en)
|
2009-11-25 |
2012-11-01 |
Rosenblum Stuart B |
Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
|
|
TWI429645B
(en)
|
2009-12-04 |
2014-03-11 |
|
Proline derivatives
|
|
US8653070B2
(en)
|
2009-12-14 |
2014-02-18 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8377980B2
(en)
*
|
2009-12-16 |
2013-02-19 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
CN102822175A
(zh)
|
2009-12-18 |
2012-12-12 |
埃迪尼克斯医药公司 |
5,5-稠合的亚芳基或亚杂芳基丙型肝炎病毒抑制剂
|
|
WO2011075607A1
(en)
|
2009-12-18 |
2011-06-23 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
|
AU2010341537A1
(en)
|
2009-12-22 |
2012-08-09 |
Merck Sharp & Dohme Corp. |
Fused Tricyclic Compounds and methods of use thereof for the treatment of viral diseases
|
|
KR20120130173A
(ko)
|
2009-12-24 |
2012-11-29 |
버텍스 파마슈티칼스 인코포레이티드 |
플라비바이러스 감염을 치료 또는 예방하기 위한 유사체들
|
|
US8362020B2
(en)
|
2009-12-30 |
2013-01-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
WO2011091446A1
(en)
|
2010-01-22 |
2011-07-28 |
Glaxosmithkline Llc |
Chemical compounds
|
|
PE20130244A1
(es)
|
2010-01-25 |
2013-03-10 |
Enanta Pharm Inc |
Inhibidores del virus de la hepatitis c
|
|
JP2013518062A
(ja)
|
2010-01-28 |
2013-05-20 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
C型肝炎阻害化合物
|
|
US8178531B2
(en)
|
2010-02-23 |
2012-05-15 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
|
US8623814B2
(en)
|
2010-02-23 |
2014-01-07 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
|
AU2010347272A1
(en)
|
2010-03-04 |
2012-09-20 |
Enanta Pharmaceuticals, Inc. |
Combination pharmaceutical agents as inhibitors of HCV replication
|
|
US8609635B2
(en)
|
2010-03-09 |
2013-12-17 |
Merck Sharp & Dohme Corp. |
Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases
|
|
AU2011232331A1
(en)
|
2010-03-24 |
2012-10-11 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of Flavivirus infections
|
|
EP2550278A1
(en)
|
2010-03-24 |
2013-01-30 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
|
EP2550268A1
(en)
|
2010-03-24 |
2013-01-30 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
|
EP2555622A4
(en)
|
2010-04-09 |
2013-09-18 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
|
US20110312996A1
(en)
|
2010-05-17 |
2011-12-22 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
|
WO2011149856A1
(en)
|
2010-05-24 |
2011-12-01 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
WO2011150243A1
(en)
|
2010-05-28 |
2011-12-01 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
WO2011153396A1
(en)
*
|
2010-06-04 |
2011-12-08 |
Enanta Pharmaceuticals, Inc |
Hepatitis c virus inhibitors
|
|
CA2802067A1
(en)
|
2010-06-09 |
2011-12-15 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a protein
|
|
WO2011154871A1
(en)
|
2010-06-10 |
2011-12-15 |
Pfizer Limited |
Hepatitis c virus inhibitors
|
|
NZ605440A
(en)
|
2010-06-10 |
2014-05-30 |
Abbvie Bahamas Ltd |
Solid compositions comprising an hcv inhibitor
|
|
WO2012003642A1
(en)
|
2010-07-09 |
2012-01-12 |
Merck Sharp & Dohme Corp. |
Fused tricyclic compounds and use thereof for treating viral diseases
|
|
CA2805440A1
(en)
|
2010-07-26 |
2012-02-09 |
Merck Sharp & Dohme Corp. |
Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
|
|
EP2598498B1
(en)
|
2010-07-26 |
2014-07-09 |
Janssen R&D Ireland |
Hetero-bicyclic derivatives as hcv inhibitors
|
|
EP2601188B1
(en)
|
2010-08-04 |
2017-10-18 |
Bristol-Myers Squibb Company |
Hepatitis c virus inhibitors
|
|
US20120196794A1
(en)
|
2010-08-06 |
2012-08-02 |
Bristol-Myers Squibb Company |
Combinations of Hepatitis C Virus Inhibitors
|
|
US20120195857A1
(en)
*
|
2010-08-12 |
2012-08-02 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
WO2012021704A1
(en)
|
2010-08-12 |
2012-02-16 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
AR082619A1
(es)
|
2010-08-13 |
2012-12-19 |
Hoffmann La Roche |
Inhibidores del virus de la hepatitis c
|
|
EP2616461A4
(en)
|
2010-08-26 |
2014-03-26 |
Rfs Pharma Llc |
POTENTIVE AND SELECTIVE INHIBITORS OF HEPATITIS C VIRUS
|
|
WO2012040389A2
(en)
|
2010-09-22 |
2012-03-29 |
Presidio Pharmaceuticals, Inc. |
Substituted bicyclic hcv inhibitors
|
|
WO2012040923A1
(en)
|
2010-09-29 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Tetracyclic indole derivatives and methods of use thereof for the treatment of viral diseases
|
|
JP2013538831A
(ja)
|
2010-09-29 |
2013-10-17 |
メルク・シャープ・エンド・ドーム・コーポレイション |
C型肝炎ウィルス感染治療のための四環式インドール誘導体
|
|
EP2621501A4
(en)
|
2010-09-29 |
2014-04-09 |
Merck Sharp & Dohme |
POLYCYCLIC HETEROCYCLUS DERIVATIVES AND METHOD FOR THEIR USE FOR THE TREATMENT OF VIRUS DISEASES
|
|
WO2012050918A2
(en)
|
2010-09-29 |
2012-04-19 |
Presidio Pharmaceutical, Inc. |
Tricyclic fused ring inhibitors of hepatitis c
|
|
CA2812779A1
(en)
|
2010-09-29 |
2012-04-19 |
Merck Sharp & Dohme Corp. |
Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
|
|
WO2012040924A1
(en)
|
2010-09-29 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Fused tetracyclic heterocycle compounds and methods of use thereof for treatment of viral diseases
|
|
EP2621932A4
(en)
|
2010-09-29 |
2014-03-26 |
Merck Sharp & Dohme |
TETRACYCLIC HETEROCYCLUS COMPOUNDS FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTIONS
|
|
WO2012048421A1
(en)
|
2010-10-14 |
2012-04-19 |
Boehringer Ingelheim International Gmbh |
Hepatitis c inhibitor compounds
|
|
WO2012061552A1
(en)
|
2010-11-04 |
2012-05-10 |
Theravance, Inc. |
Novel inhibitors of hepatitis c virus
|
|
SI2640719T1
(sl)
|
2010-11-17 |
2017-07-31 |
Gilead Pharmasset Llc |
Antivirusne spojine
|
|
RU2452735C1
(ru)
|
2010-11-30 |
2012-06-10 |
Александр Васильевич Иващенко |
Замещенные азолы, противовирусный активный компонент, фармацевтическая композиция, способ получения и применения
|
|
US20150031884A1
(en)
|
2010-12-15 |
2015-01-29 |
Abbvie Inc. |
Anti-viral compounds
|
|
US20150232455A1
(en)
|
2010-12-15 |
2015-08-20 |
Allan C. Krueger |
Anti-viral compounds
|
|
US20140364616A1
(en)
|
2010-12-15 |
2014-12-11 |
Abbvie Inc. |
Anti-viral compounds
|
|
WO2012083058A2
(en)
|
2010-12-15 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
|
WO2012083048A2
(en)
|
2010-12-15 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
|
EP2651926A4
(en)
|
2010-12-15 |
2014-07-09 |
Abbvie Inc |
ANTI-VIRAL COMPOUNDS
|
|
EP2651924A1
(en)
|
2010-12-16 |
2013-10-23 |
Abbvie Inc. |
Anti-viral compounds
|
|
CA2819894A1
(en)
|
2010-12-16 |
2012-06-21 |
Abbvie Inc. |
Anti-viral compounds
|
|
WO2012087976A2
(en)
|
2010-12-21 |
2012-06-28 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
|
WO2012123298A1
(en)
|
2011-03-11 |
2012-09-20 |
F. Hoffmann-La Roche Ag |
Antiviral compounds
|
|
WO2012122716A1
(en)
|
2011-03-17 |
2012-09-20 |
Merck Sharp & Dohme Corp. |
Tetracyclic xanthene derivatives and methods of use thereof for treatment of viral diseases
|
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
|
US9546160B2
(en)
|
2011-05-12 |
2017-01-17 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US20150105548A1
(en)
|
2011-05-26 |
2015-04-16 |
Abbvie Inc |
Anti-viral compounds
|
|
US20150126747A1
(en)
|
2011-05-26 |
2015-05-07 |
Abbvie Inc. |
Anti-viral compounds
|
|
AP2013007263A0
(en)
|
2011-05-27 |
2013-11-30 |
Achillion Pharmaceuticals Inc |
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenesuseful for treating HCV infections
|
|
US20120328565A1
(en)
|
2011-06-24 |
2012-12-27 |
Brinkman John A |
Antiviral compounds
|
|
WO2013007106A1
(zh)
|
2011-07-09 |
2013-01-17 |
广东东阳光药业有限公司 |
作为丙型肝炎病毒抑制剂的螺环化合物
|
|
US9326973B2
(en)
|
2012-01-13 |
2016-05-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|